Prevent - TOX

Ended Awarded Jan 24, 2019 Last action Jun 26, 2023

Contract number: 75N91019D00017
Awardee: University Of Illinois UEI W8XEAJDKMXH3 Part of University Of Illinois
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Task orders: 1 $3,500 obligated

Award facts

Opportunity: PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Biomarker Endpoints, Preclinical Services for Biopharmaceutical Product Development and Manufacturing, and Toxicology and Pharmacology Testing Pre-Solicitation · N01CN7701918 · Posted Apr 19, 2018

PREVENT Cancer Preclinical Drug Development Program Award Notice · Posted May 7, 2018
Combined order value: $3,500 Current and potential, with all options
Last date to order 100% complete: Jan 24, 2024
IDV ceiling <1% used: $74,995,000.00
Award type: Multiple award
Who can order: Only the awarding agency
NAICS code: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC: AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside: No set-aside
Competition: Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing: Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task order	Ordering agency	Obligated	Awarded
Task order title: contract orientation and kickoff meeting, task order period of performance: 1/25/19-2/24/19. 75N91019F00129	National Cancer Institute (NIH)	$3,500	Jan 24, 2019

Action	Obligated	Date
Supplemental Agreement for work within scope P00005	$0	Jun 26, 2023
Additional Work (new agreement, FAR part 6 applies) P00004 · Prevent cancer preclinical drug development program: toxicology and pharmacology testing	$0	Mar 28, 2023
Other Administrative Action P00003 · LFA(mpges-1/5-LOX inhibitor): preclinical studies to support a clinical trial.	$0	Nov 15, 2021
Other Administrative Action P00002 · Toxicology and pharmacology testing	$0	Aug 27, 2021
Other Administrative Action P00001	$0	May 28, 2019
Original award	$0	Jan 24, 2019

75N91019D00017 was awarded to University Of Illinois by National Cancer Institute (National Institutes of Health) on January 24, 2019.

Orders under 75N91019D00017 have obligated $3,500. 75N91019D00017's own ceiling is $74,995,000.

1 order has been placed under 75N91019D00017, the latest on January 24, 2019.

75N91019D00017 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Yes. 75N91019D00017 is part of PREVENT Preclinical Drug Development Program (PREVENT).

The extent of competition for 75N91019D00017 was full and open competition. The government received 4 offers.

On GovTribe

Try for free Login